A new class of treatment that can selectively destroy cancer cells using a light-activated viral nanoparticle has received FDA fast track designation for the treatment of ocular melanoma.
Regulatory
FDA grants fast track designation to ImmunoPulse IL-12 for melanoma
The FDA granted fast track designation to ImmunoPulse IL-12 for the treatment of metastatic melanoma that progressed during therapy with pembrolizumab or nivolumab.
Breakthrough drug which DOUBLES the survival time for people with deadly melanoma is approved for use on the NHS
A breakthrough drug which uses a man-made virus to treat advanced skin cancer has been approved for use on the NHS.
NICE rejects Roche’s melanoma combo
Patients in England and Wales with a certain type of advanced skin cancer will not be getting routine access to Roche’s Cotellic/Zelboraf combination on the NHS, after it was turned down by the National Institute for Health and Care Excellence.